RxDoctor Payments Data

David Odell, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Ann Arbor, MINPI 1033354592

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $15,000 of the $19,501 with a category attached, or 76.9%. AstraZeneca accounts for 60.7% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2022 at $11,853 and has fallen 99.8% since, to $21 in 2024.

$19,501in general payments, 2019–2025

Across 22 payments — averaging $886.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$12K
  • Boston Scientific$7K
  • Asensus Surgical, Inc.$228
  • Medtronic$219
  • Johnson & Johnson$103
  • GSK$100
  • plus $213 from 5 others

What the payments were for

  • Consulting fees$3,49118%
  • Speaking & faculty fees$15,00077%
  • Food & beverage$1,0115%

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$19,501 in reported general payments places this provider in the 80th percentile of 182 thoracic surgery (cardiothoracic vascular surgery) providers in Michigan.

See all thoracic surgery (cardiothoracic vascular surgery) providers in Michigan

Medicare billing

Part B allowed, 2024
$68,828
Medicare patients
78
Services billed
236

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other thoracic surgery (cardiothoracic vascular surgery) in Ann Arbor

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →